Gujarat Kidney And Super Speciality Limited (NSE:GKSL)
India · Delayed Price · Currency is INR 132.55
+1.57 (1.20%)
At close: Jul 10, 2026
NSE:GKSL Revenue
In the fiscal year ending March 31, 2026, Gujarat Kidney And Super Speciality had annual revenue of 820.13M INR with 103.80% growth. Gujarat Kidney And Super Speciality had revenue of 305.79M in the quarter ending March 31, 2026, with 212.59% growth.
Revenue
820.13M
Revenue Growth
+103.80%
P/S Ratio
12.74
Revenue / Employee
n/a
Employees
338
Market Cap
10.45B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 820.13M | 417.71M | 103.80% |
| Mar 31, 2025 | 402.42M | 354.68M | 742.89% |
| Mar 31, 2024 | 47.74M | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | 7.86M | -3.17M | -28.71% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kovai Medical Center and Hospital | 15.86B |
| KMC Speciality Hospitals (India) | 3.06B |
| Asarfi Hospital | 1.74B |
| KRM Ayurveda | 1.02B |
| Hannah Joseph Hospital | 920.52M |
| Nephro Care India | 887.35M |
| Shanmuga Hospital | 480.63M |
| Chennai Meenakshi Multispeciality Hospital | 370.39M |